Clinical trial
GW823093C For The Treatment Of Type 2 Diabetes Mellitus
NCT00370942 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00370942 |
|---|---|
| Title | GW823093C For The Treatment Of Type 2 Diabetes Mellitus |
| Official title | GW823093 Japan Phase IIa Mono |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | GW823093C A, GW823093C B, GW823093C C |
| Enrollment | 159 |
| Start date | Apr 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 25, 2006 |
| First posted | Sep 1, 2006 |
| Last update posted | Aug 31, 2018 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: